Hello, and a warm welcome to MedX, where we bring you the latest news and insights from the world of medicine. FDA Approves Acoltremon Ophthalmic Solution for Dry Eye Disease Relief The FDA has approved Acoltremon ophthalmic solution 0.003% (Tryptyr; Alcon) for the treatment of signs and symptoms of dry eye disease (DED). Acoltremon is the first-in

A 64-year-old male presented with a 13-month history of gradual vision loss in his right eye, reducing to hand movement perception. Initial intraocular pressure (IOP) was 50 mmHg, and he was diagnosed with advanced primary open-angle glaucoma. Despite the severity, medical treatment was initiated, and the patient underwent a successful right Mitomy

Introduction Glaucoma represents a spectrum of chronic optic neuropathies characterized by progressive visual field loss and structural damage to the optic nerve head. The primary goal of treatment is to preserve visual function by lowering intraocular pressure (IOP), the most significant modifiable risk factor. These guidelines summarize evidence-

Introduction Cataract surgery stands as one of the most frequently performed and successful surgical procedures globally. To ensure optimal patient outcomes and standardize care, the European Society of Cataract and Refractive Surgeons (ESCRS) has developed comprehensive, evidence-based guidelines. These guidelines aim to assist ophthalmic professi

Introduction: An Overview of Glaucoma Glaucoma encompasses a group of chronic, progressive optic neuropathies, characterized by the degeneration of retinal ganglion cells and corresponding visual field loss, often associated with elevated intraocular pressure (IOP) (1). It is the leading cause of irreversible blindness worldwide. There are 80 milli

Optic neuritis (ON) is an inflammatory condition leading to demyelination of the optic nerve. It is frequently linked to multiple sclerosis (MS) and, far less commonly, to neuromyelitis optica (NMO). Gradual, spontaneous improvement in visual acuity, either fully or partially, over time is the characteristic feature of ON. However, permanent defici

Introduction Glaucoma is a progressive eye disease characterized by optic nerve damage, frequently due to elevated Intraocular Pressure (IOP). It primarily affects older adults and is a leading cause of irreversible blindness worldwide. The disease involves the degeneration of retinal ganglion cells and their axons, leading to characteristic visual

Introduction Glaucoma is a progressive optic neuropathy marked by the loss of retinal ganglion cells and subsequent vision impairment. Although its exact cause remains unclear, intraocular pressure (IOP) is the only modifiable risk factor. Managing IOP is crucial to prevent vision loss, and medical therapy remains the primary treatment approach. Re

Introduction Cataracts are the leading cause of visual impairment and blindness worldwide, affecting millions of individuals, particularly in aging populations. Characterized by the clouding of the eye’s natural lens, cataracts progressively impair vision and significantly impact the quality of life. The global burden of cataract-related blindness